Sponsor:
Kailin Yang, MD, PhD
Code:
NCT07541781
Conditions
Glioma
Glioblastoma
Recurrent Glioma
Recurrent Glioblastoma
Grade 4 Malignant Glioma of Brain (Disorder)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sitagliptin
Bevacizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-12. This information was provided to ClinicalTrials.gov by Kailin Yang, MD, PhD on 2026-06-17.